11/15/2024
3:19 PM | CNS Pharmaceuticals (Filer)
| Form DEFR14A | |
11/01/2024
8:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:15 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
10/24/2024
4:27 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
10:23 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
10/23/2024
7:02 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:24 PM | CNS Pharmaceuticals (Filer)
| Form PRE 14A | |
|
09/12/2024
7:58 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:22 PM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
4:11 PM | CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:53 PM | CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
07/31/2024
11:32 AM | CNS Pharmaceuticals (Filer)
| Form RW | |
07/30/2024
4:13 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:15 PM | CNS Pharmaceuticals (Filer)
| Form 424B3 | |
07/30/2024
6:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
7:30 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
07/26/2024
7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
8:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:12 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
07/12/2024
3:30 PM | CNS Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/11/2024
6:38 PM | CNS Pharmaceuticals (Filer)
| Form 8-K/A | |
07/09/2024
10:25 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
8:49 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
07/03/2024
3:56 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
11:34 AM | CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
| Form SC 13G | |
06/27/2024
9:00 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
6:19 PM | CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
| Form SC 13G | |
06/20/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K/A | |
06/17/2024
10:17 AM | CNS Pharmaceuticals (Filer)
| Form 424B5 | |
06/14/2024
4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
05/16/2024
9:56 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/07/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
5:37 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
8:50 PM | Charles Faith L. (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:50 PM | Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Bill Gates’s Next Big AI Bet: Stargate (Ad) In February 2016… when almost nobody was talking about artificial intelligence….
I picked Nvidia as one of my favorite stocks.
Shares have jumped by more than 20,000% since then. I believe we are about to do it again with this new AI project called Stargate |
04/10/2024
8:51 PM | CNS Pharmaceuticals (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:51 PM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 PM | CNS Pharmaceuticals (Issuer)
Keyes Jeffry R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:53 PM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
6:40 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
03/28/2024
4:27 PM | CNS Pharmaceuticals (Filer)
| Form PRE 14A | |
02/14/2024
1:25 PM | ARMISTICE CAPITAL, LLC (Filed by)
CNS Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
9:26 AM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
9:27 AM | Climaco John M (Reporting)
CNS Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:27 AM | CNS Pharmaceuticals (Issuer)
Downs Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:27 AM | CNS Pharmaceuticals (Issuer)
Evans Carl Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:28 AM | CNS Pharmaceuticals (Issuer)
Gumulka Jerzy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:28 AM | CNS Pharmaceuticals (Issuer)
Mahery Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:27 PM | CNS Pharmaceuticals (Filer)
| Form 424B4 | |
01/29/2024
11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
01/23/2024
3:01 PM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
5:02 AM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
01/10/2024
4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
12/21/2023
8:15 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:36 AM | CNS Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
